We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$8.67B
AUM Growth
-$646M
Cap. Flow
+$943K
Cap. Flow %
0.01%
Top 10 Hldgs %
39.95%
Holding
321
New
142
Increased
41
Reduced
52
Closed
80

Sector Composition

1 Technology 29.39%
2 Healthcare 22.56%
3 Consumer Discretionary 11.32%
4 Industrials 9.5%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
26
Advanced Micro Devices
AMD
$808B
$138M 1.59%
+676,572
New +$144M
INTC icon
27
Intel
INTC
$478B
$132M 1.52%
+2,995,488
New +$137M
CVNA icon
28
Carvana
CVNA
$48.2B
$132M 1.52%
2,101,380
-207,990
-9% -$15.4M
SHW icon
29
Sherwin-Williams
SHW
$81.7B
$126M 1.45%
391,839
+107,522
+38% +$37M
ALAB icon
30
Astera Labs
ALAB
$52B
$105M 1.21%
955,356
-20,603
-2% -$2.93M
KO icon
31
Coca-Cola
KO
$351B
$97.7M 1.13%
1,284,612
-277,675
-18% -$21M
PM icon
32
Philip Morris
PM
$301B
$93.8M 1.08%
567,250
-1,609,777
-74% -$280M
MCD icon
33
McDonald's
MCD
$190B
$91.4M 1.05%
294,100
+281,647
+2,262% +$89.7M
MOH icon
34
Molina Healthcare
MOH
$11.7B
$86.1M 0.99%
+645,768
New +$103M
PCVX icon
35
Vaxcyte
PCVX
$8.12B
$80.1M 0.92%
1,377,738
+23,501
+2% +$1.28M
NVO
36
Novo Nordisk
NVO
$223B
$76.4M 0.88%
+2,080,121
New +$98.6M
WVE icon
37
Wave Life Sciences
WVE
$1.12B
$73.7M 0.85%
10,161,399
+881,162
+9% +$11.5M
CNTA
38
DELISTED
Centessa Pharmaceuticals
CNTA
$73.7M 0.85%
1,854,488
+210,764
+13% +$5.39M
NAMS icon
39
NewAmsterdam Pharma
NAMS
$3.7B
$70M 0.81%
2,186,402
+292,176
+15% +$9.52M
FLR icon
40
Fluor
FLR
$6.85B
$66M 0.76%
+1,415,557
New +$65.9M
BSX icon
41
CALL
Boston Scientific
BSX
$65.4B
$62.8M 0.72%
+1,000,000
New +$80M
GLW icon
42
Corning
GLW
$133B
$50.9M 0.59%
+374,507
New +$45.2M
MIR icon
43
Mirion Technologies
MIR
$3.91B
$49.3M 0.57%
+2,649,879
New +$59.8M
MMSI icon
44
Merit Medical Systems
MMSI
$4.41B
$49.2M 0.57%
714,081
+227,915
+47% +$17.8M
MELI icon
45
Mercado Libre
MELI
$92B
$46.5M 0.54%
26,894
+745
+3% +$1.44M
ROIV icon
46
Roivant Sciences
ROIV
$24.8B
$45.1M 0.52%
+1,626,940
New +$41.8M
COMP icon
47
Compass
COMP
$8.97B
$37.8M 0.44%
5,172,396
-7,464,810
-59% -$78.4M
MDLN
48
Medline Inc
MDLN
$33.6B
$35.4M 0.41%
796,077
ACHC icon
49
Acadia Healthcare
ACHC
$3.17B
$30.7M 0.35%
1,314,116
+408,697
+45% +$7.4M
IVVD icon
50
Invivyd
IVVD
$219M
$24.7M 0.28%
18,970,913

Similar funds

Maverick Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Maverick Capital held 321 positions worth $8.67B, down 6.9% from $9.32B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Maverick Capital's Q1 2026 filing shows 142 new, 41 increased, 52 reduced and 80 closed positions. Its largest new stake was Infleqtion Inc: 19,941,924 shares worth $196M. The largest sale was Union Pacific, an estimated $304M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Maverick Capital's largest Q1 2026 buy was Infleqtion Inc: 19,941,924 shares worth $196M.
  • Maverick Capital added most to Nu Holdings in Q1 2026, an estimated $174M increase.
  • Maverick Capital's biggest Q1 2026 reduction was Philip Morris, cutting an estimated $280M.
  • Maverick Capital fully exited Union Pacific in Q1 2026, selling an estimated $304M.
  • Maverick Capital's ten largest holdings make up 40% of its $8.67B portfolio in Q1 2026.
  • Maverick Capital opened 142 new positions and closed 80 in Q1 2026.
  • Maverick Capital's portfolio value fell 6.9% quarter-over-quarter to $8.67B.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.